3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Breast Neoplasms
5
Pain
2
Obesity
1
Myotoxicity
1
Lymphoma
1
Inflammation
1
Hot Flashes
1
Drug-Related Side Effects and Adverse Reactions
1
Chronic Pain
1
Breast Cancer Patient
1
Agnosia
1
Interventions
palbociclib
2
Ketorolac
2
dapagliflozin
1
Tablets
1
Surgical Procedures, Operative
1
Sulindac
1
Specimen Handling
1
Rivaroxaban
1
Resistance Training
1
Radiotherapy, Conformal
1
Probiotics
1
Pregabalin
1
Plastic Surgery Procedures
1
Omeprazole
1
Neoadjuvant Therapy
1
Methods
1
Mastectomy
1
Massage
1
Losartan
1
Ibuprofen
1
Fish Oils
1
Exercise
1
Cognitive Behavioral Therapy
1
Bevacizumab
1
Art Therapy
1
Anti-Inflammatory Agents, Non-Steroidal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Pregabalin
×
Breast
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled